Health secretary to set out further plans on ordering some travellers into quarantine hotels
- Oxford trial to test efficacy of mix of vaccines for individuals
- Closed doors and lives in limbo: young Britons face Covid jobs crisis
- Care homes still breaking rules despite fatal outbreaks, inspectors say
- Global coronavirus updates – live
A government-backed study is being launched to determine whether different coronavirus vaccines can safely be used for the first and second doses.
The programme, which has received 7 million in funding from the government’s Vaccine Taskforce, aims to establish whether a mixed-dose vaccine regimen is better than, or a good alternative to, using two doses of the same Covid-19 jab, the PA reports.
Given the inevitable challenges of immunising large numbers of the population against Covid-19 and potential global supply constraints, there are definite advantages to having data that could support a more flexible immunisation programme, if needed and if approved by the medicines regulator.
It is also even possible that by combining vaccines, the immune response could be enhanced giving even higher antibody levels that last longer; unless this is evaluated in a clinical trial we just won’t know.”
It will report probably after the summer and of course it will have no impact on the deployment.
If you have currently had the Pfizer/BioNTech vaccine, you will get your Pfizer/BioNTech vaccine as your second dose, your booster dose.
The health secretary Matt Hancock will today make an announcement on further plans to order some travellers into hotel quarantine, prime minister Boris Johnson said.
It’s very unlikely that the current vaccine won’t be effective on the variants whether in Kent or other variants especially when it comes to severe illness and hospitalisation.
All manufacturers, Pfizer-BioNTech, Moderna, Oxford-AstraZeneca and others are looking at how they can improve their vaccine to make sure that we are ready for any variant – there are about 4,000 variants around the world of Covid now.